Compounds useful as chemokine receptor antagonists
US7635698B2 · kind B2 · utility
19Cited by
15References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2005 |
| Grant date | Dec 22, 2009 |
| Priority date | — |
| Expiry date | Aug 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided:or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.